Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
5
×
boston blog main
boston top stories
5
×
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
5
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
5
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biotech
eli lilly
pfizer
abbvie
cancer
cancer immunotherapy
deals
fda
glaxosmithkline
johnson & johnson
What
bio
roundup
drug
news
alzheimer’s
biogen’s
biotech
days
nash
week
aducanumab
alliance
amyloid
angst
annual
approval
assessed
attention
august
bagged
billions
biogen
biopharmaceutical
brammer
bristol
busy
buy
calls
changing
color
communities
companies
conference
convo
crispr
decisions
devices
drugs
earlier
effects
Language
unset
Current search:
biogen
×
" san francisco top stories "
×
" bristol-myers squibb "
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More